Novavax (NVAX) Reports RSV F Vaccine Phase 3 Missed Primary, Secondary Efficacy Objectives
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 4/25/2024
- Wall Street stocks fall as weak GDP growth spreads rate-cut gloom
- Q1 US GDP shows surprise slowing and uncomfortable inflation
- Alphabet (GOOGL) soars 16% on Q1 results beat, first-ever dividend
- Meta shares dip on softer Q2 revenue guidance, elevated AI spending plans
- Oil settles higher as weak U.S. economic growth offset by supply concerns
- IBM tumbles on soft Q1 revenue; announces HashiCorp $6.4bn acquisition
- Hasbro (HAS) brand strength sees earnings top expectations
- Meta Platforms (META) Tops Q1 EPS by 39c, Offers Guidance
- Seagate Technology (STX) Enters $600M Asset Purchase Agreement with Avago
- Rubrik (RBRK) Prices Upsized 23.5M Share IPO at $32/sh
- After-hours movers: Alphabet, Microsoft, Snap, Intel, and more
- Midday movers: Meta, IBM, Caterpillar fall; Chipotle rises
- After-hours movers: Meta, Ford, IBM, ServiceNow and more
- Midday movers: Tesla, Boeing rise; Uber, Old Dominion Freight fall
- After-hours movers: Tesla, Texas Instruments, Seagate, Visa and more
JPMorgan Downgrades Novavax (NVAX) to Neutral
September 16, 2016 6:55 AM EDTJPMorgan downgraded Novavax (NASDAQ: NVAX) from Overweight to Neutral and removed its price target (prior $11.00).
For an analyst ratings summary and ratings history on Novavax click here. For more ratings news on Novavax click here.
Shares of Novavax closed at $8.34 yesterday.
... MorePiper Jaffray Downgrades Novavax (NVAX) to Neutral
September 16, 2016 6:54 AM EDTPiper Jaffray downgraded Novavax (NASDAQ: NVAX) from Overweight to Neutral with a price target of $1.00 (from $14.00).
For an analyst ratings summary and ratings history on Novavax click here. For more ratings news on Novavax click here.
Shares of Novavax closed at $8.34 yesterday.
... MoreWedbush Downgrades Novavax (NVAX) to Neutral
September 16, 2016 6:48 AM EDTWedbush downgraded Novavax (NASDAQ: NVAX) from Outperform to Neutral with a price target of $2.00 (from $14.00) after the company posted surprising results last night with its RSV vaccine failing a pivotal study in the elderly
Analsyt Heather Behanna commented, "RSV rates were significantly lower... More
Novavax (NVAX) trading halted with news pending
September 15, 2016 4:00 PM EDTNovavax (NASDAQ: NVAX) trading halted with news pending.
... MoreStocks with Implied Volatility Movement
September 15, 2016 5:15 AM EDTNovavax (NASDAQ: NVAX) implied volatility at upper end of index mean range
... MoreStocks with Implied Volatility Movement
September 14, 2016 5:25 AM EDTNovavax (NASDAQ: NVAX) implied volatility at upper end of index mean range
... More
